natgillin/translations-raw huggingface dataset:
¾ The Member States must ensure that the education plans for health care professionals and patients contain the measures to minimise the risks as detailed below, 
¾ Države članice morajo zagotoviti, da načrti izobraževanja zdravstvenih delavcev in bolnikov vsebujejo spodaj navedena merila za zmanjnševanje tveganja:
• An educational plan for patients, which is aimed at risk minimisation and to support safe and effective use for the product. 
• Načrt izobraževanja bolnikov, katerega cilj je zmanjšanjšati tveganje in podpirati varno in učinkovito uporabo zdravila.
CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE ADDRESSED TO THE MEMBER STATES 
POGOJI ALI OMEJITVE GLEDE VARNE IN UČINKOVITE UPORABE ZDRAVILA, KI JIH MORAJO IZPOLNITI DRŽAVE ČLANICE
• An educational plan for physicians and health care providers, which is aimed at risk minimisation and to support safe and effective use for the product. 
• Načrt izobraževanja zdravnikov in drugih zdravstvenih delavcev, katerega cilj je zmanjšanjšati tveganje in podpirati varno in učinkovito uporabo zdravila.
Invented name Strength Pharmaceutical Form Route of Administration 
Številka EU Izmišljeno imejakost farmacevtska oblika ovojnina vsebina velikost pakiranja
5 pre-filled syringes 
5 nepolnjenih injekcijskih brizg
Subcutaneous use 
pot uporabe
No specific measures are usually required. 
Običajno posebni ukrepi niso potrebni.
Before you start 
Preden začnete
Do not use any other sort of water. 
Ne uporabljajte druge vrste vode.
If blood appears: 
Če se pojavi kri:
(See next section ‘How much to use'). 
(glejte naslednje poglavje 'Koliko zdravila uporabiti').
Your doctor will tell you the exact date and time. 
Zdravnik vam bo povedal točen datum in uro.
Wash your hands • It is important that your hands and the things you use are as clean as possible. 
Umijte si roke • Pomembno je, da so vaše roke in stvari, ki jih uporabljate, kar se da čiste.
• This medicine is only for you - do not let anyone else use it. 
• To zdravilo je le za vas - ne dovolite, da bi ga uporabil kdo drug.
Lay out everything you need on a clean surface: 
Vse, kar potrebujete, položite na čisto površino:
Unopened vial: 2 years 
Neodprta viala: 2 leti.
Your doctor or nurse will show you how to prepare and inject the medicine. 
Zdravnik ali medicinska sestra vam bosta pokazala, kako pripraviti in injicirati zdravilo.
• Hold the syringe in one hand - like you would hold a pencil. 
• Brizgo držite v eno roki - kot bi držali svinčnik.
DATE OF REVISION OF THE TEXT {DD/MM/YYYY} 
DATUM ZADNJE REVIZIJE BESEDILA {DD/MM/LLLL}
If blood appears, follow Step 5 below. 
Če se pojavi kri, sledite navodilom v 5. koraku spodaj.
Do not use this medicine if you notice that the white powder in the vial has changed in appearance. 
Ne uporabljajte tega zdravila, če opazite, da se je belemu prašku v viali spremenil videz.
You can choose to inject every morning or every evening. 
Zdravilo lahko injicirate vsako jutro ali vsak večer.
It stops eggs being released straight away. 
Preprečuje takojšnje sproščanje jajčec.
The adverse reactions reported below are classified according to frequency of occurrence as follows: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000). 
Poročani neželeni učinki so v nadaljevanju razvrščeni po pogostnosti, kot sledi: zelo pogosti (≥1/10), pogosti (≥1/100 do <1/10), občasni (≥1/1.000 do <1/100), redki (≥1/10.000 do <1/1.000), zelo redki
Cetrorelix is not to be used in the presence of any of the conditions listed below: 
Cetroreliksa se ne sme uporabljati v prisotnosti katerega od spodaj navedenih stanj:
It is best to use the medicine at the same time each day, leaving 24 hours between each dose. 
Najbolje je vzeti zdravilo vsak dan ob istem času tako, da je razmak med posameznimi odmerki 24 ur.
Based on your ovarian response, your doctor may decide to start on another day. 
Na podlagi odziva vaših jajčnikov se lahko zdravnik odloči za začetek na drug dan.
Luteal phase support should be given according to the reproductive medical centre´s practice. 
Podpora lutealne faze mora potekati v skladu z ustaljeno prakso zdravstvenega centra za reprodukcijo.
• Turn the vial upside down. 
• Vialo obrnite navzdol.
The effect of the medicine will last for longer. 
Delovanje zdravila bo podaljšano.
Administration in the morning 
Uporaba zjutraj
• Before starting to use this medicine, please read these instructions the whole way through first. 
• Preden začnete uporabljati to zdravilo, najprej v celoti preberite ta navodila.
This event must be considered as an intrinsic risk of the stimulation procedure with gonadotropins 
Ta dogodek moramo upoštevati kot intrinzično tveganje postopka stimulacije z gonadotropini.
The onset of suppression is virtually immediate and is maintained by continuous treatment, without initial stimulatory effect. 
Supresija je takojšnja in se vzdržuje s stalnim zdravljenjem, brez začetnega stimulativnega učinka.
Overdosage in humans may result in a prolonged duration of action but is unlikely to be associated with acute toxic effects. 
Preveliko odmerjanje lahko pri človeku povzroči podaljšano delovanje, vendar je malo verjetno, da bi bilo povezano z akutnimi toksičnimi učinki.
Distribution The volume of distribution (Vd) is 1.1 L x kg 
Porazdelitev Volumen porazdelitve (Vd) je 1,1 l x kg
You may be having a possible serious, life-threatening allergic reaction to the medicine. 
Morda boste imeli hude, življenjsko nevarne alergijske reakcije na zdravilo.
Repeated ovarian stimulation procedure 
Ponovljen postopek ovarijske stimulacije
• wash your hands and start again with a new vial and pre-filled syringe. 
• Umijte si roke in začnite znova z novo vialo in napolnjeno brizgo.
Your doctor will carefully look at the benefits and risks for you, if you need to have Cetrotide during more than one cycle. 
Vaš zdravnik bo pozorno preučil koristi in tveganja v primeru, da bi morali zdravilo Cetrotide prejemati v več kot enem ciklusu.
Therefore, cetrorelix should be used in repeated cycles only after a careful benefit/risk evaluation. 
Zato smemo cetroreliks uporabiti v večkratnih ciklusih samo po natančni oceni razmerja koristi/tveganja.
- The other ingredients are: 
• Druge sestavine zdravila so:
• if you have severe kidney disease. 
• če imate hudo ledvično bolezen.
Do not use Cetrotide if any of the above applies to you. 
Ne uporabljajte zdravila Cetrotide če katera od zgornjih navedb velja za vas.
Remove from the refrigerator approximately 30 minutes before use. 
Iz hladilnika ga vzemite približno 30 minut pred uporabo.
Children and adolescents Cetrotide is not indicated for the use in children and adolescents. 
Otroci in mladostniki Zdravilo Cetrotide ni indicirano za uporabo pri otrocih in mladostnikih.
DATE OF FIRST AUTHORISATION / RENEWAL OF THE AUTHORISATION Date of first authorisation: 13 April 1999 
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM Datum prve odobritve: 13. april 1999 Datum zadnjega podaljšanja: 13. april 2009
• Use each needle, vial and syringe only once. 
• Vsako iglo, vialo in injekcijsko brizgo uporabite le enkrat.
• Do not touch the grey needle and do not let the needle touch any surface. 
• Sive igle se ne dotikajte in ne dovolite, da bi se z iglo dotaknili katere koli površine.
However, the possibility of interactions with gonadotropins or medicinal products that may induce histamine release in susceptible individuals, cannot be totally excluded. 
Vendar možnosti medsebojnega delovanja z gonadotropini ali zdravili, ki pri občutljivih posameznikih lahko sprožijo sproščanje histamina, ni mogoče popolnoma izključiti.
This may indicate that the ovaries over-reacted to the treatment and that large ovarian cysts developed. 
To lahko pomeni, da so se jajčniki prekomerno odzvali na zdravljenje in da so se razvile velike ovarijske ciste.
If you look from the side through the gap in the rubber stopper, you can control the movement of the needle and the liquid. 
Če od strani pogledate skozi režo v gumijastem zamašku, lahko nadzorujete gibanje igle in tekočine.
In case you pulled out the plunger with the plunger stopper by mistake, make sure to discard the dose as sterility will be lost, and prepare a new dose (and restart from step 1). 
V primeru, da ste bat z batnim zamaškom pomotoma izvlekli, zagotovite, da bo odmerek zavržen, ker ne bo več sterilen, in pripravite nov odmerek (in ponovno začnite s 1. korakom).
Following the first administration, it is advised that the patient be kept under medical supervision for 30 minutes to ensure there is no allergic/pseudo-allergic reaction to the injection. 
Po prvi uporabi je priporočljivo, da bolnica ostane pod zdravniškim nadzorom še 30 minut, da se prepričamo, da nima alergijske/psevdoalergijske reakcije na injekcijo.
Absorption The absolute bioavailability of cetrorelix after subcutaneous administration is about 85%. 
Absorpcija Absolutna biološka uporabnost cetroreliksa po subkutani uporabi je približno 85 %.
It should be removed from the refrigerator approximately 30 minutes before use. 
Iz hladilnika ga je treba vzeti približno 30 minut pred uporabo.
• If you forget a dose, inject it as soon as you remember and talk to your doctor. 
• Če ste pozabili uporabiti odmerek zdravila, si ga injicirajte takoj ko se spomnite in se posvetujte z zdravnikom.
• There will be a rubber stopper underneath - keep this in the vial. 
• Pod njim bo gumijasti zamašek - obdržite ga v viali.
The prevalence of congenital anomalies after the use of assisted reproductive technologies (ART) with or without GnRH antagonists may be slightly higher than after spontaneous conceptions although it is unclear whether this is related to factors inherent to the couple's infertility or the ART procedures. 
Prevalenca prirojenih okvar po uporabi tehnik asistirane reprodukcije (ART) z antagonisti GnRH ali brez njih je morda malenkost višja kot po spontanih zanositvah, čeprav ni jasno, ali je to povezano z dejavniki, ki so lastni neplodnosti para ali postopkom ART.
There is limited experience up to now with the administration of cetrorelix during a repeated ovarian stimulation procedure. 
Do danes imamo le omejene izkušnje z uporabo cetroreliksa pri ponovljenem postopku ovarijske stimulacije.
You then start using Cetrotide a few days later. 
Nato nekaj dni kasneje začnete uporabljati zdravilo Cetrotide.
• LH stimulates ovulation during your menstrual cycle. 
• LH stimulira ovulacijo med menstrualnim ciklusom.
• During pregnancy and lactation. 
• Med nosečnostjo in dojenjem.
Pregnancy and breast-feeding Cetrotide is not intended to be used during pregnancy and lactation (see section 4.3). 
Nosečnost in dojenje Zdravilo Cetrotide ni namenjeno za uporabo v času nosečnosti in dojenja (glejte poglavje 4.3).
This is because if the eggs are released too early (premature ovulation) it may not be possible for your doctor to collect them. 
Če se jajčeca sprostijo prezgodaj (prezgodnja ovulacija), jih vaš zdravnik morda ne bo mogel odvzeti.
Cetrotide should only be prescribed by a specialist experienced in this field. 
Zdravilo Cetrotide sme predpisovati samo specialist z izkušnjami na tem področju.
After reconstitution: use immediately 
Po rekonstituciji: uporabite takoj.
Cetrotide is one of the medicines used during ‘assisted reproductive techniques' to help you get pregnant. 
Zdravilo Cetrotide je eno od zdravil, ki se uporablja pri 'tehnikah asistirane reprodukcije', s katerimi vam pomagajo zanositi.
The start of Cetrotide may be delayed in absence of follicular growth, although clinical experience is based on starting Cetrotide on day 5 or day 6 of stimulation. 
Začetek zdravljenja z zdravilom Cetrotide se lahko zakasni, če ni rasti folikla, vendar klinične izkušnje temeljijo na začetku uporabe zdravila Cetrotide na 5. ali 6. dan stimulacije.
• In the powder: mannitol. 
• V prašku: manitol.
Pregnancy and breast-feeding Do not use Cetrotide if you are pregnant, think you may be pregnant, or if you are breast-feeding. 
Nosečnost in dojenje Zdravila Cetrotide ne uporabljajte, če ste noseči, menite, da bi lahko bili noseči ali če dojite.
Additionally, for each vial the pack contains: 
Pakiranje za vsako vialo vsebuje še:
In clinical trials, these effects were observed with a frequency of 9.4% following multiple injections of Cetrotide 0.25 mg. 
V kliničnih študijah so te učinke opazili s pogostnostjo 9,4 % po več injekcijah zdravila Cetrotide 0,25 mg.
An OHSS should be treated symptomatically, e.g. with rest, intravenous electrolytes/colloids and heparin therapy. 
OHSS moramo zdraviti simptomatsko, npr. s počitkom, intravenskimi elektroliti/koloidi in heparinsko terapijo.
To reduce skin irritation, select a different part of your belly each day. 
Da bi zmanjšali draženje kože, vsak dan izberite drug predel na trebuhu.
EXP After reconstitution, use immediately. 
EXP Po rekonstituciji uporabite takoj.
This is when your follicles develop too much and become large cysts. 
To je stanje, ko se folikli preveč razvijejo in postanejo velike ciste.
Pharmacotherapeutic group: anti-gonadotropin-releasing hormones, ATC code: H01CC02. 
Farmakoterapevtska skupina: antagonisti gonadotropin sproščajočih hormonov, oznaka ATC: H01CC02.
Take care not to pull out completely the plunger with the attached plunger stopper. 
Bodite previdni, da bata s pritrjenim batnim zamaškom ne izvlečete v celoti.
In clinical trials Cetrotide was used with human menopausal gonadotropin (HMG), however, limited experience with recombinant follicle-stimulating hormone (FSH) suggested similar efficacy. 
V kliničnih študijah so zdravilo Cetrotide uporabljali s humanim menopavznim gonadotropinom (HMG), vendar pa omejene izkušnje z rekombinantnim folikle stimulirajočim hormonom (FSH) kažejo podobno učinkovitost.
MARKETING AUTHORISATION NUMBER(S) EU/1/99/100/001 
ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/99/100/001
• Hypersensitivity to the active substance or any structural analogues of gonadotropin-releasing hormone (GnRH), extrinsic peptide hormones or to any of the excipients listed in section 6.1. 
• Preobčutljivost na učinkovino ali kateri koli strukturni analog gonadotropin sproščajočega hormona (GnRH), eksogene peptidne hormone ali katero koli pomožno snov, navedeno v poglavju 6.1.
This means that Cetrotide stops the chain of events that leads to an egg being released from your ovary. 
To pomeni, da zdravilo Cetrotide blokira verigo dogodkov, zaradi katerih se jajčece sprosti iz jajčnika.
Do not freeze or place next to the freezer compartment or a freezer pack. 
Ne zamrzujte in ne dajajte v bližino zamrzovalnega predala ali zamrzovalnega vložka.
• If no blood appears, slowly push the plunger in to inject your medicine. 
• Če se kri ne pojavi, bat počasi potiskajte navzdol, da injicirate zdravilo.
• if you are allergic to cetrorelix or any of the other ingredients of this medicine (listed in section 6). 
• če ste alergični na cetroreliks ali katero koli sestavino tega zdravila (navedeno v poglavju 6),
• You can carry out the following injections yourself as long as your doctor has made you aware of the symptoms that may indicate allergy and of the possibly serious or life-threatening consequences that would need immediate treatment (see section 4 ‘Possible side effects'). 
• Naslednje injekcije si lahko dajete sami, pod pogojem, da vas je zdravnik seznanil z znaki, ki lahko kažejo na alergijo in o hudih, življenjsko nevarnih posledicah, ki zahtevajo takojšnjo zdravniško pomoč (glejte poglavje 4 'Možni neželeni učinki').
• Make sure that you collect all of your medicine from the vial. 
• Prepričajte se, da ste iz viale povlekli celotno količino zdravila.
If you forget to use Cetrotide 
Če ste pozabili uporabiti zdravilo Cetrotide
Allergic reactions - Warm, red skin, itching (often in your groin or armpits), red, itchy, raised areas (hives), runny nose, fast or uneven pulse, swelling of your tongue and throat, sneezing, wheezing or serious difficulty breathing, or dizziness. 
• Vroča, pordela koža, srbenje (pogosto v dimljah ali pazduhah), rdeča, srbeča, dvignjena področja (izpuščaji), izcedek iz nosu, hiter ali neenakomeren srčni utrip, otekanje jezika in grla, kihanje, sopenje ali hude težave z dihanjem ali omotičnost.
The first administration of Cetrotide should be performed under the supervision of a physician and under conditions where treatment of possible allergic/pseudo-allergic reactions (including life-threatening anaphylaxis) is immediately available. 
Prvo dajanje zdravila Cetrotide se mora izvesti pod nadzorom zdravnika in v pogojih, kjer je zdravljenje možnih alergijskih/psevdoalergijskih reakcij (vključno z življenjsko nevarno anafilaktično reakcijo) takoj na voljo.
• if you are pregnant or breast-feeding. 
• če ste noseči ali dojite,
The injection site reactions may be minimised by rotating the injection sites, delaying injection at the same site and injecting the medicinal product in a slow rate to facilitate the progressive absorption of the medicinal product. 
Reakcije na mestu injiciranja se lahko zmanjša, če se mesto injiciranja menjuje, s čimer se injiciranje na isto mesto časovno preloži, in če se zdravilo injicira počasi, da se omogoči postopno absorpcijo zdravila.
The starting day of Cetrotide is depending on the ovarian response, i.e. the number and size of growing follicles and/or the amount of circulating oestradiol. 
Začetek dajanja zdravila Cetrotide je odvisen od odziva jajčnikov, tj. števila in velikosti rastočih foliklov in/ali količine estradiola v krvi.
6.6 Special precautions for disposal and other handling This medicinal product must be allowed to reach room temperature prior to injection. 
6.6 Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom Zdravilo mora pred injiciranjem doseči sobno temperaturo.
Special care should be taken in women with signs and symptoms of active allergic conditions or known history of allergic predisposition. 
Posebna pozornost je potrebna pri ženskah z znaki in simptomi aktivnih alergijskih stanj ali s potrjeno alergijsko predispozicijo v anamnezi.
• two alcohol swabs. 
• dve alkoholni blazinici.
• Do not inject a double dose to make up for a forgotten dose. 
• Ne injicirajte si dvojnega odmerka, če ste pozabili uporabiti prejšnji odmerek.
Cetrorelix is contraindicated in patients with severe renal impairment (see section 4.3). 
Cetroreliks je kontraindiciran pri bolnicah s hudo ledvično okvaro (glejte poglavje 4.3).
• Put the cap back on the needles so that they are safe to be thrown away. 
• Na igle ponovno namestite zaporko, da jih lahko varno zavržete.
Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques. 
Preprečevanje prezgodnje ovulacije pri bolnicah v postopku nadzorovane ovarijske stimulacije, ki ji sledi odvzem oocitov in tehnike asistirane reprodukcije.
• To remove air bubbles, gently flick the syringe until all the air collects at the top - then slowly push the plunger in until the air bubbles are gone. 
• Da odstranite mehurčke, s prsti nežno udarjajte po brizgi, da se vsi mehurčki zberejo na vrhu - nato počasi potiskajte bat, dokler vsi mehurčki ne izginejo.
In women undergoing ovarian stimulation the duration of action of cetrorelix is dose dependent. 
Pri ženskah v postopku ovarijske stimulacije, je trajanje delovanja cetroreliksa odvisno od odmerka.
Elimination The total plasma clearance and the renal clearance are 1.2 mL x min x kg and 0.1 mL x min x kg respectively. 
Izločanje Celotni plazemski in ledvični očistek sta 1,2 ml x min x kg oziroma 0,1 ml x min x kg
• if you are allergic to medicines similar to Cetrotide (any other peptide hormones). 
• če ste alergični na zdravila, podobna zdravilu Cetrotide (druge peptidne hormone),
The following injections may be self-administered as long as the patient is made aware of the signs and symptoms that may indicate hypersensitivity, the consequences of such a reaction and the need for immediate medical intervention. 
Nadaljnje injekcije si lahko bolnica daje sama, če je seznanjena z znaki in simptomi, ki lahko kažejo na preobčutljivostno reakcijo, posledicami takšne reakcije in potrebo po takojšnjem zdravniškem ukrepanju.
Mixing the powder and water in the vial 
Mešanje praška in vode v viali
If you are not sure, talk to your doctor before using this medicine. 
Če ste negotovi, se pred začetkom uporabe tega zdravila posvetujte z zdravnikom.
The mean terminal half-lives following intravenous and subcutaneous administration are about 12 h and 30 h, respectively, demonstrating the effect of absorption processes at the injection site. 
Povprečen končni razpolovni čas po intravenski in subkutani uporabi je približno 12 ur oziroma 30 ur, kar dokazuje učinek procesa absorpcije na mestu injiciranja.
This medicine stops your body from releasing an egg from your ovary (ovulation) during your menstrual cycle. 
To zdravilo prepreči, da bi vaše telo med menstrualnim ciklusom sprostilo jajčece iz jajčnika (ovulacija).
• empty your medicine into a sink and follow Step 6 below 
• Zdravilo izpraznite v korito in sledite navodilom v 6. koraku spodaj.
• Your doctor must supervise your first injection. 
• Dajanje prve injekcije se mora izvesti pod nadzorom vašega zdravnika.
Cases of allergic/pseudoallergic reactions, including life-threatening anaphylaxis with the first dose have been reported (see section 4.8). 
Poročali so o primerih alergijskih/psevdoalergijskih reakcij, vključno z življenjsko nevarno anafilaktično reakcijo ob prvem odmerku (glejte poglavje 4.8).
Administration in the evening 
Uporaba zvečer
Do not use Cetrotide 
Ne uporabljajte zdravila Cetrotide
When your eggs are ready to be collected, another medicine will be given to you that will release them (ovulation induction). 
Ko bodo vaša jajčeca pripravljena za odvzem, boste prejeli drugo zdravilo, ki bo jajčeca sprostilo (indukcija ovulacije).
During or after you receive these medicines, you may develop OHSS. 
Med jemanjem teh zdravil ali po tem lahko pride do OHSS.
Adding the water from the pre-filled syringe to the powder in the vial 
Dodajanje vode iz napolnjene brizge k prašku v viali
The contents of 1 vial (0.25 mg cetrorelix) are to be administered once daily, at 24 h intervals, either in the morning or in the evening. 
Vsebino 1 viale (0,25 mg cetroreliksa) je treba injicirati enkrat na dan, v 24-urnih razmakih, bodisi zjutraj ali zvečer.
For possible signs to look out for and what to do if this happens see section 4 ‘Possible side effects'. 
Za možne simptome, na katere morate biti pozorni, in za ukrepanje v teh primerih glejte poglavje 4 'Možni neželeni učinki'.
Cetrotide has no or negligible influence on the ability to drive and use machines. 
Zdravilo Cetrotide nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
What you need to know before you use Cetrotide 
Kaj morate vedeti, preden boste uporabili zdravilo Cetrotide
Due to this mode of action, cetrorelix controls the secretion of gonadotropins (LH and FSH). 
Zaradi takega načina delovanja, cetroreliks uravnava izločanje gonadotropinov (LH in FSH).
INFORMATION IN BRAILLE cetrotide 0.25 mg 
PODATKI V BRAILLOVI PISAVI cetrotide 0,25 mg
The entire contents of the vial should be withdrawn to ensure a delivery to the patient of a dose of at least 0.23 mg cetrorelix. 
V brizgo je treba potegniti celotno vsebino viale, da zagotovite, da bolnica prejme najmanj 0,23 mg cetroreliksa.
Limited data from clinical follow-up studies in 316 newborns of women administered cetrorelix for infertility treatments suggest that cetrorelix does not increase the risk of congenital anomalies in the offsprings. 
Omejeni podatki dopolnilnih kliničnih študij pri 316 novorojencih žensk, ki so se zaradi neplodnosti zdravile s cetroreliksom, kažejo, da cetroreliks ne povečuje tveganja prirojenih okvar pri potomcih.
Local reactions at the injection site (e.g. erythema, swelling and pruritus). 
lokalne reakcije na mestu injiciranja (npr. eritem, oteklina in srbenje).
No teratogenic effects occurred when the medicinal product was administered during the sensitive phase of gestation. 
Pri uporabi zdravila med občutljivo fazo gestacije se niso pojavili teratogeni učinki.